AstraZeneca (AZN)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4595.00p Today's change: +1.56%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4595.00p 5 day change: +1.35%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4595.00p 6 month change: -9.74%

Contact details

Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com

Company information

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca shares slipped over one per cent after warning many of its patents will run out during 2017. [...]

2 February 2017
Views
456

AstraZeneca is forecast to report disappointing results this week as competition continues to drag on sales. [...]

29 January 2017
Views
548

London's top share index hit a fresh all-time high yesterday, setting a record for the longest winning streak [...]

11 January 2017
Shares
15
Views
310

2016's events made fools of most pundits, and looking back at my column exactly a year ago, I fared little better. [...]

6 January 2017
Shares
9
Views
1,232

Pharmaceutical giant AstraZeneca has bagged $550m (£446m) in an initial payment from the sale of its late-stage [...]

23 December 2016
Shares
7
Views
469

AstraZeneca's biological arm MedImmune and US life sciences group Abpro have joined forces on a new research [...]

30 November 2016
Shares
1
Views
185

FTSE 100 pharma firm Hikma has cut its full-year sales guidance for its US generics business to roughly $600m, [...]

10 November 2016
Views
378

AstraZeneca posted weak quarterly profits this morning, but big pharma companies are expected to benefit from [...]

10 November 2016
Views
154

Pharmaceutical stocks – one of the few sectors that was thought to be privately if not publicly hoping for a [...]

9 November 2016
Shares
2
Views
577

Drug giant AstraZeneca, which reports its third quarter results on Thursday, is expected to remain under pressure [...]

6 November 2016
Shares
1
Views
329

Pharmaceuticals bosses are set to meet with ministers next month in a bid to press their case for government support [...]

30 October 2016
Shares
2
Views
489

Drug giant AstraZeneca has struck a deal with Ireland-based pharma firm Allergan to licence a treatment for [...]

3 October 2016
Views
185

The NHS watchdog is drawing up plans to start charging companies fees to get new drugs approved. [...]

2 October 2016
Shares
1
Views
133

Shares in Cambridge-based pharma firm Sareum have shot up by 130 per cent after it announced its up-coming cancer [...]

27 September 2016
Views
249

Big pharma firm AstraZeneca has been forced to withdraw a marketing application for a new cancer drug, due [...]

21 September 2016
Views
170

Content tagged with "AstraZeneca"